Exposure data for pharmacovigilance -: Methods and parameters

被引：0
|
作者：
Bahri, P.
Begaud, B.
Moore, N.
机构：
[1] Univ Bordeaux 2, F-33076 Bordeaux, France
[2] Hop Pellegrin, Lab Pharmacol Clin & Toxicol, F-33076 Bordeaux, France
来源：
DRUG SAFETY | 2006年 / 29卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
70
引用
收藏
页码：948 / 948
页数：1
相关论文
共 50 条
  • [21] Data quality management in pharmacovigilance
    Lindquist, M
    DRUG SAFETY, 2004, 27 (12) : 857 - 870
  • [22] In-utero ART exposure and the need for pharmacovigilance
    Mofenson, Lynne M.
    LANCET GLOBAL HEALTH, 2018, 6 (07): : E716 - E717
  • [23] PHARMACOVIGILANCE OF HYPOLIPIDEMIC DRUGS - A RETROSPECTIVE STUDY OF THE DATA OF THE FRENCH SYSTEM OF PHARMACOVIGILANCE
    LAVARENNE, J
    THERAPIE, 1991, 46 (05): : 345 - 346
  • [24] The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance
    Cooper, Dawn
    Platt, Robert W.
    van Hunsel, Florence
    Davies, Miranda
    Yeomans, Alison
    Lane, Samantha
    Shakir, Saad
    CLINICAL THERAPEUTICS, 2024, 46 (07) : 565 - 569
  • [25] Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature
    Brahim Azzouz
    Aurore Morel
    Lukshe Kanagaratnam
    Emmanuelle Herlem
    Thierry Trenque
    Drug Safety, 2019, 42 : 1507 - 1513
  • [26] Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature
    Azzouz, Brahim
    Morel, Aurore
    Kanagaratnam, Lukshe
    Herlem, Emmanuelle
    Trenque, Thierry
    DRUG SAFETY, 2019, 42 (12) : 1507 - 1513
  • [27] DATA SOURCES AND METHODS FOR ASCERTAINING HUMAN EXPOSURE TO DRUGS
    JONES, JK
    KENNEDY, DL
    JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1984, 21 (1-2): : 237 - 251
  • [28] Data Management in Pharmacovigilance: Challenges and complexities
    Chopra, M.
    DRUG SAFETY, 2017, 40 (10) : 995 - 996
  • [29] Exploiting Heterogeneous Open Data for Pharmacovigilance
    Koutkias, V.
    Lillo-Le Louet, A.
    Jaulent, M. C.
    DRUG SAFETY, 2015, 38 (10) : 950 - 951
  • [30] Multivariate Analysis for Visualizing Pharmacovigilance Data
    Hauben, M.
    DRUG SAFETY, 2015, 38 (10) : 956 - 957
12345